Future Directions

Although the incidence of new HCV infections in the United States is declining, the number of individuals infected for more than 20 years who are at risk for serious complications is expected to increase until about the year 2015. In the 15 years since the discovery of HCV, the major route of transmission through blood transfusion has all but been eliminated, improvements in therapy have resulted in better response rates, and molecular tests have proven invaluable in the diagnosis and management of patients with HCV. As new therapies evolve and laboratory assays change, the clinical relevance and use of laboratory tests will evolve.

0 0

Post a comment